| 000 | 01603cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030603.0 | ||
| 008 | 120314s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2012.Eb.B | ||
| 100 | 0 | _aEbtsam Mohammed Abdou Mohammed | |
| 245 | 1 | 2 |
_aA biopharmaceutical study on a proton pump inhibitor / _cEbtsam Mohammed Abdou Mohammed ; Supervised Mona Hassan Aboulelnien , Nadia Abdelkader Soliman |
| 246 | 1 | 5 | _aدراسة بيوصيدلية على عقار مثبط لمضخة البروتون |
| 260 |
_aCairo : _bEbtsam Mohammed Abdou Mohammed , _c2012 |
||
| 300 |
_a190 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aRabeprazole solium is a potent proton pump inhibitor used to relieve symptoms of gastroesophageal reflux disease (GERD) gastric ulceration and acute upper gastrointestinal bleeding . It is a prodrug which is absorbed unchanged from the intestinal wall then converted to its active form which has inhibitory effect on the ATP -as enzyme in the gastric parietal cells | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBioavailability | |
| 653 | 4 | _aDisintegrants | |
| 653 | 4 | _aRabeprazole | |
| 700 | 0 |
_aMona Hassan Aboulelnien , _eSupervisor |
|
| 700 | 0 |
_aNadia Abdelkader Soliman , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37851 _d37851 |
||